Michael Palfreyman

Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium.

Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA.

Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The private company is based in Southborough.

Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California.

Psychiatric Genomics, Inc. developed innovative small molecule drugs. It identified gene expression patterns associated with psychiatric diseases. The company was incorporated on June 21, 2000 and was headquartered in Rockville, MD.

FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA.

Marc Pharmaceuticals, Inc. operates as a development stage pharmaceutical company. The company is headquartered in Stamford, CT.